Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark J. Murray Insider Profile
4 Followers
Mark J. Murray, President & CEO, Director at Arbutus Biopharma, holds 341.40K shares in Arbutus Biopharma (Ticker: ABUS). Most recently, Mark J. Murray Bought $25,000 shares of Arbutus Biopharma on Nov 30, 2018 for an estimated value of 33.75K.
Mark J. Murray Arbutus Biopharma (ABUS)President & CEO, Director
Arbutus Biopharma (ABUS)
President & CEO, Director
Ranked #68,496 out of 78,624 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-34.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Mark J. Murray holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark J. Murray
Mark J. Murray's Trading History
List of latest transactions for each holding click on a transaction to see Mark J. Murray's performance on stock
You May Also Like
Mark J. Murray insider profile FAQ
What is the percentage of profitable transactions made by Mark J. Murray?
The percentage of profitable transactions made by Mark J. Murray is 25%.
What is the average return per transaction made by Mark J. Murray?
The average return per transaction made by Mark J. Murray is -34.10%.
What stocks does Mark J. Murray hold?
Mark J. Murray holds: ABUS stocks.
What was Mark J. Murray’s latest transaction?
Mark J. Murray latest transaction was an Informative Buy of $33.75K.
What was Mark J. Murray's most profitable transaction?
Mark J. Murray’s most profitable transaction was an Informative Buy of ABUS stock on June 20, 2016. The return on the trade was 8.80%.
What is Mark J. Murray's role in Arbutus Biopharma?
Mark J. Murray's role in Arbutus Biopharma is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.